ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 293

Measurement of Advanced Glycation Endproducts in the Skin of Patients with Idiopathic Inflammatory Myopathies

Simone Barsotti1, Chiara Saponaro2, Rosaria Talarico3, Alessandra Tripoli4, Claudia Ferrari5, Elisabetta Bianchini6, Nicole Di Lascio6, Melania Gaggini2, Amalia Gastaldelli2, Marta Mosca7, Maria Aurora Morales6 and Rossella Neri5, 1Division of Rheumatology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy, 2National Research Council, Institute of Clinical Physiology, Pisa, Italy, 3Rheumatology Unit, University of Pisa, Italy, Pisa, Italy, 4University of Pisa, Rheumatology Unit, Pisa, Italy, 5Internal Medicine, University of Pisa, Pisa, Italy, 6Institute of Clinical Physiology, CNR, Pisa, Italy, 7University of Pisa, Pisa, Italy

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Cardiovascular disease, myositis and risk assessment

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2015

Title: Muscle Biology, Myositis and Myopathies Poster

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

Many data suggest that advanced glycation endproducts (AGEs) play an important role the development of atherosclerosis and cardiovascular (CV) disease. AGEs are produced and may accumulate during chronic inflammation, and may impact on patients with idiopathic inflammatory myositis (IIM). The aims of this study was to evaluate whether AGEs are increased in patients with IIM and to explore whether AGE accumulation is related to clinical data, disease activity and measures of subclinical atherosclerosis assessed by ultrasonography sampling of carotid artery. 

Methods: Twenty-seven IIM patients (F/M 19/8; mean age 56.7±12.3; mean disease duration 8.8±7 years, 13 polymyositis and 14 dermatomyositis) fulfilling the Bohan and Peter criteria were prospectively enrolled and compared with 29 healthy subjects (HS) matched for age, sex and classical cardiovascular risk factors (smoking habits, diabetes mellitus, hypertension, family history of CV disease, body mass index). AGEs were determined by skin autofluorescence at level of left forearm.

AGEs levels were correlated with demographic data, disease activity parameters (physician and patient’s activity using visual analogic scale, manual muscle test 8, muscular enzyme levels, health quality assessment questionnaire), disease duration, cumulative corticosteroids dose. We also collected markers of subclinical atherosclerosis including Intima-Media-Thickness (IMT), mean arterial diameter (mAD) and distensibility coefficient (DC) measured on B-mode ultrasound image sequences of right common carotid artery, 1 cm beneath the bifurcation. 

Results:

IIM patients presented higher subcutaneous AGEs than healthy subjects. (mean 2.83 ± 0.6360 DS vs 2.176 ±0.5773 DS) p<0.001.

In the IIM group, AGEs are significantly correlated with age (p=0.011), and with IMT (p<0.001) and mAD (p=0.035), while no correlation was found with DC. In healthy subjects, AGEs were significantly correlated with age (p<0.001), but no correlations were found between AGEs and IMT, mAD and DC.

In addition, in myositis patients, no correlations were observed between AGEs and gender, classic cardiovascular risk factors, disease duration, cumulative corticosteroid dose, disease activity parameters and laboratory data.

Conclusion:

Our data have shown that IIM patients presented higher AGEs than healthy subjects; a correlation between AGEs and age at the evaluation, and between AGEs and signs of premature atherosclerosis were found. These observations may suggest that, in myositis patients, AGEs may be an early marker of subclinical CV. Further data are necessary to confirm our observation.


Disclosure: S. Barsotti, None; C. Saponaro, None; R. Talarico, None; A. Tripoli, None; C. Ferrari, None; E. Bianchini, None; N. Di Lascio, None; M. Gaggini, None; A. Gastaldelli, None; M. Mosca, None; M. A. Morales, None; R. Neri, None.

To cite this abstract in AMA style:

Barsotti S, Saponaro C, Talarico R, Tripoli A, Ferrari C, Bianchini E, Di Lascio N, Gaggini M, Gastaldelli A, Mosca M, Morales MA, Neri R. Measurement of Advanced Glycation Endproducts in the Skin of Patients with Idiopathic Inflammatory Myopathies [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/measurement-of-advanced-glycation-endproducts-in-the-skin-of-patients-with-idiopathic-inflammatory-myopathies/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/measurement-of-advanced-glycation-endproducts-in-the-skin-of-patients-with-idiopathic-inflammatory-myopathies/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology